Advertisement

Index by author

July 01, 2018; Volume 70,Issue 3

A

  1. Albuquerque, Edson X.

    1. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
      Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198

B

  1. Bankhead, Armand

    1. Current Challenges and Opportunities in Treating Glioblastoma
      Open Access
      Current Challenges and Opportunities in Treating Glioblastoma
      Andrea Shergalis, Armand Bankhead, Urarika Luesakul, Nongnuj Muangsin and Nouri Neamati
      Eric L. Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 412-445; DOI: https://doi.org/10.1124/pr.117.014944

  2. Barker, Eric L.

    1. Current Challenges and Opportunities in Treating Glioblastoma
      Open Access
      Current Challenges and Opportunities in Treating Glioblastoma
      Andrea Shergalis, Armand Bankhead, Urarika Luesakul, Nongnuj Muangsin and Nouri Neamati
      Eric L. Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 412-445; DOI: https://doi.org/10.1124/pr.117.014944

  3. Bartova, L.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

  4. Berry, Mark D.

    1. Open Access
      Trace Amines and Their Receptors
      Raul R. Gainetdinov, Marius C. Hoener and Mark D. Berry
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 549-620; DOI: https://doi.org/10.1124/pr.117.015305

C

  1. Calabrese, F.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

  2. Calvo, David

    1. Mechanisms and Drug Development in Atrial Fibrillation
      Mechanisms and Drug Development in Atrial Fibrillation
      David Calvo, David Filgueiras-Rama and José Jalife
      Lori L. Isom, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 505-525; DOI: https://doi.org/10.1124/pr.117.014183

  3. Caraci, F.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

D

  1. Dalwadi, Dhwanil A.

    1. Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs
      Dhwanil A. Dalwadi, Luis Ozuna, Brian H. Harvey, Michelle Viljoen and John A. Schetz
      Charles P. France, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 684-711; DOI: https://doi.org/10.1124/pr.117.013706

  2. Dold, M.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

  3. Dowdle, Logan T.

    1. Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development
      Colleen A. Hanlon, Logan T. Dowdle and J. Scott Henderson
      Michael A. Nader, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 661-683; DOI: https://doi.org/10.1124/pr.116.013649

  4. Drago, F.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

F

  1. Fabbri, C.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

  2. Filgueiras-Rama, David

    1. Mechanisms and Drug Development in Atrial Fibrillation
      Mechanisms and Drug Development in Atrial Fibrillation
      David Calvo, David Filgueiras-Rama and José Jalife
      Lori L. Isom, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 505-525; DOI: https://doi.org/10.1124/pr.117.014183

  3. France, Charles P.

    1. Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs
      Dhwanil A. Dalwadi, Luis Ozuna, Brian H. Harvey, Michelle Viljoen and John A. Schetz
      Charles P. France, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 684-711; DOI: https://doi.org/10.1124/pr.117.013706

G

  1. Gainetdinov, Raul R.

    1. Open Access
      Trace Amines and Their Receptors
      Raul R. Gainetdinov, Marius C. Hoener and Mark D. Berry
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 549-620; DOI: https://doi.org/10.1124/pr.117.015305

  2. Georgiou, Polymnia

    1. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
      Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198

  3. Gould, Todd D.

    1. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
      Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198

H

  1. Hanlon, Colleen A.

    1. Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development
      Colleen A. Hanlon, Logan T. Dowdle and J. Scott Henderson
      Michael A. Nader, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 661-683; DOI: https://doi.org/10.1124/pr.116.013649

  2. Harvey, Brian H.

    1. Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs
      Dhwanil A. Dalwadi, Luis Ozuna, Brian H. Harvey, Michelle Viljoen and John A. Schetz
      Charles P. France, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 684-711; DOI: https://doi.org/10.1124/pr.117.013706

  3. Henderson, J. Scott

    1. Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development
      Colleen A. Hanlon, Logan T. Dowdle and J. Scott Henderson
      Michael A. Nader, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 661-683; DOI: https://doi.org/10.1124/pr.116.013649

  4. Hepler, John R.

    1. Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease
      Katherine E. Squires, Carolina Montañez-Miranda, Rushika R. Pandya, Matthew P. Torres and John R. Hepler
      Alan V. Smrcka, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 446-474; DOI: https://doi.org/10.1124/pr.117.015354

  5. Highland, Jaclyn N.

    1. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
      Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198

  6. Hoener, Marius C.

    1. Open Access
      Trace Amines and Their Receptors
      Raul R. Gainetdinov, Marius C. Hoener and Mark D. Berry
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 549-620; DOI: https://doi.org/10.1124/pr.117.015305

  7. Holinstat, Michael

    1. Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases
      Jennifer Yeung, Wenjie Li and Michael Holinstat
      Lori L. Isom, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 526-548; DOI: https://doi.org/10.1124/pr.117.014530

I

  1. Isom, Lori L.

    1. Mechanisms and Drug Development in Atrial Fibrillation
      Mechanisms and Drug Development in Atrial Fibrillation
      David Calvo, David Filgueiras-Rama and José Jalife
      Lori L. Isom, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 505-525; DOI: https://doi.org/10.1124/pr.117.014183
    2. Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases
      Jennifer Yeung, Wenjie Li and Michael Holinstat
      Lori L. Isom, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 526-548; DOI: https://doi.org/10.1124/pr.117.014530

J

  1. Jalife, José

    1. Mechanisms and Drug Development in Atrial Fibrillation
      Mechanisms and Drug Development in Atrial Fibrillation
      David Calvo, David Filgueiras-Rama and José Jalife
      Lori L. Isom, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 505-525; DOI: https://doi.org/10.1124/pr.117.014183

K

  1. Kasper, S.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

L

  1. Leggio, G. M.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

  2. Li, Wenjie

    1. Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases
      Jennifer Yeung, Wenjie Li and Michael Holinstat
      Lori L. Isom, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 526-548; DOI: https://doi.org/10.1124/pr.117.014530

  3. Luesakul, Urarika

    1. Current Challenges and Opportunities in Treating Glioblastoma
      Open Access
      Current Challenges and Opportunities in Treating Glioblastoma
      Andrea Shergalis, Armand Bankhead, Urarika Luesakul, Nongnuj Muangsin and Nouri Neamati
      Eric L. Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 412-445; DOI: https://doi.org/10.1124/pr.117.014944

M

  1. Mendlewicz, J.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

  2. Moaddel, Ruin

    1. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
      Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198

  3. Molteni, R.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

  4. Montañez-Miranda, Carolina

    1. Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease
      Katherine E. Squires, Carolina Montañez-Miranda, Rushika R. Pandya, Matthew P. Torres and John R. Hepler
      Alan V. Smrcka, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 446-474; DOI: https://doi.org/10.1124/pr.117.015354

  5. Morris, Patrick J.

    1. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
      Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198

  6. Muangsin, Nongnuj

    1. Current Challenges and Opportunities in Treating Glioblastoma
      Open Access
      Current Challenges and Opportunities in Treating Glioblastoma
      Andrea Shergalis, Armand Bankhead, Urarika Luesakul, Nongnuj Muangsin and Nouri Neamati
      Eric L. Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 412-445; DOI: https://doi.org/10.1124/pr.117.014944

N

  1. Nader, Michael A.

    1. Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development
      Colleen A. Hanlon, Logan T. Dowdle and J. Scott Henderson
      Michael A. Nader, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 661-683; DOI: https://doi.org/10.1124/pr.116.013649

  2. Neamati, Nouri

    1. Current Challenges and Opportunities in Treating Glioblastoma
      Open Access
      Current Challenges and Opportunities in Treating Glioblastoma
      Andrea Shergalis, Armand Bankhead, Urarika Luesakul, Nongnuj Muangsin and Nouri Neamati
      Eric L. Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 412-445; DOI: https://doi.org/10.1124/pr.117.014944

O

  1. Ohlstein, Eliot H.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

  2. Ozuna, Luis

    1. Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs
      Dhwanil A. Dalwadi, Luis Ozuna, Brian H. Harvey, Michelle Viljoen and John A. Schetz
      Charles P. France, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 684-711; DOI: https://doi.org/10.1124/pr.117.013706

P

  1. Pandya, Rushika R.

    1. Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease
      Katherine E. Squires, Carolina Montañez-Miranda, Rushika R. Pandya, Matthew P. Torres and John R. Hepler
      Alan V. Smrcka, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 446-474; DOI: https://doi.org/10.1124/pr.117.015354

  2. Pereira, Edna F. R.

    1. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
      Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198

R

  1. Racagni, G.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

  2. Riggs, Lace M.

    1. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
      Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198

  3. Riva, M. A.

    1. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
      F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva and F. Drago
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 475-504; DOI: https://doi.org/10.1124/pr.117.014977

S

  1. Schetz, John A.

    1. Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs
      Dhwanil A. Dalwadi, Luis Ozuna, Brian H. Harvey, Michelle Viljoen and John A. Schetz
      Charles P. France, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 684-711; DOI: https://doi.org/10.1124/pr.117.013706

  2. Shergalis, Andrea

    1. Current Challenges and Opportunities in Treating Glioblastoma
      Open Access
      Current Challenges and Opportunities in Treating Glioblastoma
      Andrea Shergalis, Armand Bankhead, Urarika Luesakul, Nongnuj Muangsin and Nouri Neamati
      Eric L. Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 412-445; DOI: https://doi.org/10.1124/pr.117.014944

  3. Smrcka, Alan V.

    1. Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease
      Katherine E. Squires, Carolina Montañez-Miranda, Rushika R. Pandya, Matthew P. Torres and John R. Hepler
      Alan V. Smrcka, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 446-474; DOI: https://doi.org/10.1124/pr.117.015354

  4. Squires, Katherine E.

    1. Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease
      Katherine E. Squires, Carolina Montañez-Miranda, Rushika R. Pandya, Matthew P. Torres and John R. Hepler
      Alan V. Smrcka, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 446-474; DOI: https://doi.org/10.1124/pr.117.015354

T

  1. Thomas, Craig J.

    1. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
      Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198

  2. Torres, Matthew P.

    1. Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease
      Katherine E. Squires, Carolina Montañez-Miranda, Rushika R. Pandya, Matthew P. Torres and John R. Hepler
      Alan V. Smrcka, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 446-474; DOI: https://doi.org/10.1124/pr.117.015354

V

  1. Viljoen, Michelle

    1. Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs
      Dhwanil A. Dalwadi, Luis Ozuna, Brian H. Harvey, Michelle Viljoen and John A. Schetz
      Charles P. France, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 684-711; DOI: https://doi.org/10.1124/pr.117.013706

W

  1. Witkin, Jeffrey M.

    1. Open Access
      Trace Amines and Their Receptors
      Raul R. Gainetdinov, Marius C. Hoener and Mark D. Berry
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 549-620; DOI: https://doi.org/10.1124/pr.117.015305
    2. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
      Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198

Y

  1. Yeung, Jennifer

    1. Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases
      Jennifer Yeung, Wenjie Li and Michael Holinstat
      Lori L. Isom, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 526-548; DOI: https://doi.org/10.1124/pr.117.014530

Z

  1. Zanos, Panos

    1. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
      Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198

  2. Zarate, Carlos A.

    1. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
      Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198
Back to top

In this issue

Advertisement